Perturbations of Telmisartan Alone and in Combination with Ranolazineor Dapagliflozin on the Amplitude and Gating of Voltage-gated Na+ Current in Neuroblastoma Neuronal Cells

Abstract

A recent study investigated the correlation between telmisartan (TEL) exposure and Alzheimer’s disease (AD) risk among African Americans (AAs) and European Americans. Their findings indicated that moderate-to-high TEL exposure was linked to a decreased incidence of AD among AAs. These results suggest a potential association between TEL and a reduced risk of AD specifically within the AA population. Here, we investigated the effects of TEL, either alone or in combination with ranolazine (Ran) or dapagliflozin (Dapa), on voltage-gated Na+ currents (INa) in Neuro-2a cells. TEL, primarily used for treating hypertension and cardiovascular disorders, showed a stimulatory effect on INa, while Ran and Dapa reversed this stimulation. In Neuro-2a cells, we demonstrated that with exposure to TEL, the transient (INa(T)) and late (INa(L)) components of INa were differentially stimulated with effective EC50’s of 16.9 and 3.1 μM, respectively. The research implies that TEL’s impact on INa might be associated with enhanced neuronal excitability. This study highlights the complex interplay between TEL, Ran, and Dapa on INa and their potential implications for AD, emphasizing the need for further investigation to understand the mechanisms involved.

Keywords

• dapagliflozin
• neuroblastoma neuro-2a cells
• ranolazine
• telmisartan
• voltage-gated na+ currents (ina)